The DOI matches its Crossref record; 444 of the 444 references it cites were found in a registry or an index.
Insulin Receptor Isoforms in Physiology and Disease: An Updated View
Open accessAbstract
The insulin receptor (IR) gene undergoes differential splicing that generates two IR isoforms, IR-A and IR-B. The physiological roles of IR isoforms are incompletely understood and appear to be determined by their different binding affinities for insulin-like growth factors (IGFs), particularly for IGF-2. Predominant roles of IR-A in prenatal growth and development and of IR-B in metabolic regulation are well established. However, emerging evidence indicates that the differential expression of IR isoforms may also help explain the diversification of insulin and IGF signaling and actions in various organs and tissues by involving not only different ligand-binding affinities but also different membrane partitioning and trafficking and possibly different abilities to interact with a variety of molecular partners. Of note, dysregulation of the IR-A/IR-B ratio is associated with insulin resistance, aging, and increased proliferative activity of normal and neoplastic tissues and appears to sustain detrimental effects. This review discusses novel information that has generated remarkable progress in our understanding of the physiology of IR isoforms and their role in disease. We also focus on novel IR ligands and modulators that should now be considered as an important strategy for better and safer treatment of diabetes and cancer and possibly other IR-related diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–400 of 444
Interaction between the Grb10 SH2 Domain and the Insulin Receptor Carboxyl Terminus
Hansen, H. F., Svensson, U., Zhu, J.-W., Laviola, L., Giorgino, F., Wolf, G., Smith, R. J., & Riedel, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.8882 · Cited by 102
A Kinase-Independent Role for Unoccupied Insulin and IGF-1 Receptors in the Control of Apoptosis
Boucher, J., Macotela, Y., Bézy, O., Mori, M. A., Kriauciunas, K. M., & Kahn, C. R. (2010) · Science Signaling · doi:10.1126/scisignal.2001173 · Cited by 102
A Small-Molecule Furin Inhibitor Inhibits Cancer Cell Motility and Invasiveness
Coppola, J. M., Bhojani, M. S., Ross, B. D., & Rehemtulla, A. (2008) · Neoplasia · doi:10.1593/neo.08166 · Cited by 101
Garwood, C. J., Ratcliffe, L. E., Morgan, S. V., Simpson, J. E., Owens, H., Vazquez-Villaseñor, I., Heath, P. R., Romero, I. A., Ince, P. G., & Wharton, S. B. (2015) · Molecular Brain · doi:10.1186/s13041-015-0138-6 · Cited by 101
Hakomori, S., & Handa, K. (2015) · Glycoconjugate Journal · doi:10.1007/s10719-014-9572-4 · Cited by 99
Vásquez, G., Sanhueza, F., Vásquez, R., González, M., Martín, R. S., Casanello, P. C., & Sobrevía, L. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.068288 · Cited by 99
Nuclear Signaling by Receptor Tyrosine Kinases: The First Robin of Spring
Schlessinger, J., & Lemmon, M. A. (2006) · Cell · doi:10.1016/j.cell.2006.09.013 · Cited by 98
Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation
Sprynski, A. C., Hose, D., Kassambara, A., Vincent, L., Jourdan, M., Rossi, J., Goldschmidt, H., & Klein, B. (2010) · Leukemia · doi:10.1038/leu.2010.192 · Cited by 98
Shimizu, T., Sugihara, E., Yamaguchi‐Iwai, S., Tamaki, S., Koyama, Y., Kamel, W., Ueki, A., Ishikawa, T., Chiyoda, T., Osuka, S., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0914 · Cited by 97
Further Exploration of the Relationship Between Insulin Glargine and Incident Cancer
Morden, N. E., Liu, S. K., Smith, J., MacKenzie, T. A., Skinner, J., & Korc, M. (2011) · Diabetes Care · doi:10.2337/dc11-0699 · Cited by 97
Syndromes of Autoimmunity and Hypoglycemia: Autoantibodies Directed Against insulinand Its Receptor
Taylor, S. I., Barbetti, F., Accili, D., Roth, J., & Görden, P. (1989) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30392-x · Cited by 94
Bedinger, D., & Adams, S. H. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.08.013 · Cited by 94
Abbas, A., Imrie, H., Viswambharan, H., Sukumar, P., Rajwani, A., Cubbon, R. M., Gage, M., Smith, J., Galloway, S. L., Yuldasheva, N. Y., et al. (2011) · Diabetes · doi:10.2337/db11-0197 · Cited by 94
Insulin-Like Growth Factor Physiology
Holly, J. M. P., & Perks, C. M. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.04.009 · Cited by 93
Fox, E. M., Kuba, M. G., Miller, T. W., Davies, B. R., & Arteaga, C. L. (2013) · Breast Cancer Research · doi:10.1186/bcr3449 · Cited by 92
Yang, W., Jeong, H., Park, S., & Lee, W. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500107 · Cited by 91
Malakar, P., Chartarifsky, L., Hija, A., Leibowitz, G., Gläser, B., Dor, Y., & Karni, R. (2016) · Scientific Reports · doi:10.1038/srep31222 · Cited by 90
IGF-II Promotes Stemness of Neural Restricted Precursors
Ziegler, A. N., Schneider, J., Qin, M., Tyler, W. A., Pintar, J. E., Fraidenraich, D., Wood, T. L., & Levison, S. W. (2012) · Stem Cells · doi:10.1002/stem.1095 · Cited by 89
Yoshino, H., Enokida, H., Chiyomaru, T., Tatarano, S., Hidaka, H., Yamasaki, T., Gotanda, T., Tachiwada, T., Nohata, N., Yamane, T., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.12.011 · Cited by 89
Morcavallo, A., Genua, M., Palummo, A., Kletvíková, E., Jiráček, J., Brzozowski, A. M., Iozzo, R. V., Belfiore, A., & Morrione, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.252478 · Cited by 89
Self-citationMARCH1 regulates insulin sensitivity by controlling cell surface insulin receptor levels
Nagarajan, A. G., Petersen, M. C., Nasiri, A. R., Butrico, G. M., Fung, A. C. H., Ruan, H., Kursawe, R., Caprio, S., Thibodeau, J., Bourgeois‐Daigneault, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms12639 · Cited by 89
Potentially important microRNA cluster on chromosome 17p13.1 in primary peritoneal carcinoma
Flavin, R., Smyth, P. C., Laios, A., O’Toole, S. A., Barrett, C., Finn, S. P., Russell, S., Ring, M., Denning, K. M., Li, J., et al. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.135 · Cited by 88
A novel insulin receptor-signaling platform and its link to insulin resistance and type 2 diabetes
Alghamdi, F., Guo, M., Abdulkhalek, S., Crawford, N., Amith, S. R., & Szewczuk, M. R. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.02.015 · Cited by 87
β-Cell Hyperplasia Induced by Hepatic Insulin Resistance
Escribano, Ó., Guillén, C., Nevado, C., Gómez‐Hernández, A., Kahn, C. R., & Benito, M. (2009) · Diabetes · doi:10.2337/db08-0551 · Cited by 87
Jiang, K., Patel, N. A., Watson, J. E., Apostolatos, H. S., Kleiman, E., Hanson, O., Hagiwara, M., & Cooper, D. R. (2008) · Endocrinology · doi:10.1210/en.2008-0818 · Cited by 86
Desbuquois, B., Carré, N., & Burnol, A. (2012) · FEBS Journal · doi:10.1111/febs.12080 · Cited by 86
Sen, S., Talukdar, I., Liu, Y. M., Tam, J. W. O., Reddy, S., & Webster, N. J. G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.095224 · Cited by 85
High-Affinity Insulin Binding: Insulin Interacts with Two Receptor Ligand Binding Sites
Whittaker, L. J., Hao, C., Fu, W., & Whittaker, J. (2008) · Biochemistry · doi:10.1021/bi801693h · Cited by 85
Shields, B. M., Knight, B., Hopper, H., Hill, A., Powell, R. J., Hattersley, A. T., & CLARK, P. M. S. (2007) · Diabetes Care · doi:10.2337/dc06-1501 · Cited by 84
Kosaki, A., Nelson, J., & Webster, N. J. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10331 · Cited by 83
The insights of Let‐7 miRNAs in oncogenesis and stem cell potency
Sun, X., Liu, J., Xu, C., Tang, S., & Ren, H. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12861 · Cited by 83
Hepatocyte Growth Factor Plays a Key Role in Insulin Resistance-Associated Compensatory Mechanisms
Araújo, T. G., Oliveira, A. G., Carvalho, B. M., Guadagnini, D., Protzek, A. O. P., Carvalheira, J. B. C., Boschero, A. C., & Saad, M. J. A. (2012) · Endocrinology · doi:10.1210/en.2012-1496 · Cited by 82
Targeting mutant p53 in cancer: a long road to precision therapy
Mantovani, F., Walerych, D., & Sal, G. D. (2016) · FEBS Journal · doi:10.1111/febs.13948 · Cited by 81
Heidegger, I. M., Kern, J., Ofer, P., Klocker, H., & Massoner, P. (2014) · Oncotarget · doi:10.18632/oncotarget.1884 · Cited by 80
Bhaskar, V., Goldfine, I. D., Bedinger, D., Lau, A., Kuan, H. F., Gross, L. M., Handa, M., Maddux, B. A., Watson, S. R., Zhu, S., et al. (2012) · Diabetes · doi:10.2337/db11-1578 · Cited by 80
Wu, J. W., Filion, K. B., Azoulay, L., Doll, M. K., & Suissa, S. (2016) · Diabetes Care · doi:10.2337/dc15-1816 · Cited by 80
Matà, R., Palladino, C., Nicolosi, M. L., Presti, A. R. L., Malaguarnera, R., Ragusa, M., Sciortino, D., Morrione, A., Maggiolini, M., Vella, V., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6524 · Cited by 80
Self-citationChapter 3 Molecular Mechanisms of Differential Intracellular Signaling From the Insulin Receptor
Jensen, M., & MEYTS, P. D. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00603-1 · Cited by 79
N‐linked glycans of the human insulin receptor and their distribution over the crystal structure
Sparrow, L. G., Lawrence, M. C., Gorman, J. J., Strike, P. M., Robinson, C. P., McKern, N. M., & Ward, C. W. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21768 · Cited by 79
Self-citationSarfstein, R., & Werner, H. (2013) · Endocrinology · doi:10.1210/en.2012-2165 · Cited by 78
Proliferative effects of insulin analogues on mammary epithelial cells
Mayer, D., Shukla, A. K., & Enzmann, H. G. (2008) · Archives of Physiology and Biochemistry · doi:10.1080/13813450801900645 · Cited by 78
Yang, W., Jeong, H.-J., Park, S., & Lee, W. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.09.006 · Cited by 78
The insulin receptor translocates to the nucleus to regulate cell proliferation in liver
Amaya, M. J., de Oliveira, A. G., Guimarães, E. S., Casteluber, M. C. D. F., Carvalho, S. M., de Andrade, L. M., Pinto, M. C. X., Mennone, A., Oliveira, C. A., Resende, R. R., et al. (2013) · Hepatology · doi:10.1002/hep.26609 · Cited by 78
MicroRNA-424 may function as a tumor suppressor in endometrial carcinoma cells by targeting E2F7.
Li, Q., Qiu, X., Li, Q., Wang, X., Li, L., Xu, M., Dong, M., & Xiao, Y.-B. (2015) · Oncology Report · doi:10.3892/or.2015.3812 · Cited by 76
The insulin‐like growth factor I receptor regulates glucose transport by astrocytes
Hernández-Garzón, E., Fernandez, A. M., Pérez‐Alvarez, A., Genís, L., Bascuñana, P., de la Rosa, R. F., Delgado, M., Pozo, M. A., Moreno, E., McCormick, P. J., et al. (2016) · Glia · doi:10.1002/glia.23035 · Cited by 76
Creevey, L., Ryan, J., Harvey, H. M., Bray, I. M., Meehan, M., Khan, A. R., & Stallings, R. L. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-23 · Cited by 75
Sacco, A., Morcavallo, A., Pandini, G., Vigneri, R., & Belfiore, A. (2009) · Endocrinology · doi:10.1210/en.2009-0377 · Cited by 74
Self-citationBudi, E. H., Muthusamy, B.-P., & Derynck, R. (2015) · Science Signaling · doi:10.1126/scisignal.aaa9432 · Cited by 74
Awasthi, N., Zhang, C., Ruan, W., Schwarz, M. A., & Schwarz, R. E. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0447 · Cited by 73
Acquired Mutations That Affect Pre-mRNA Splicing in Hematologic Malignancies and Solid Tumors
Scott, L. M., & Rebel, V. I. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt257 · Cited by 73
Pierre‐Eugène, C., Pagésy, P., Nguyen, T. T., Neuillé, M., Tschank, G., Tennagels, N., Hampe, C., & Issad, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041992 · Cited by 72
Hou, X., Huang, F., Macedo, L. F., Harrington, S. C., Reeves, K. A., Greer, A. L., Finckenstein, F. G., Brodie, A., Gottardis, M. M., Carboni, J. M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1080 · Cited by 72
hnRNP A1 and hnRNP F Modulate the Alternative Splicing of Exon 11 of the Insulin Receptor Gene
Talukdar, I., Sen, S., Urbano, R., Thompson, J. X., Yates, J. R., & Webster, N. J. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027869 · Cited by 72
Highly specific role of the insulin receptor in breast cancer progression
Rostoker, R., Abelson, S., Bitton-Worms, K., Genkin, I., Ben-Shmuel, S., Dakwar, M., Orr, Z. S., Caspi, A., Tzukerman, M., & LeRoith, D. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0490 · Cited by 72
Yunn, N.-O., Koh, A., Han, S., Lim, J. H., Park, S., Lee, J., Kim, E., Jang, S. K., Berggren, P., & Ryu, S. H. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv767 · Cited by 71
Alvino, C. L., Ong, S. C., McNeil, K. A., Delaine, C. A., Booker, G. W., Wallace, J. C., & Forbes, B. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027488 · Cited by 70
miR-103/107 modulates multidrug resistance in human gastric carcinoma by downregulating Cav-1
Zhang, Y., Qu, X., Li, C., Fan, Y., Che, X., Wang, X., Cai, Y., Hu, X., & Liu, Y. (2014) · Tumor Biology · doi:10.1007/s13277-014-2835-7 · Cited by 70
Strong Association between Serum Hepatocyte Growth Factor and Metabolic Syndrome
Hiratsuka, A., Adachi, H., Fujiura, Y., Yamagishi, S., Hirai, Y., Enomoto, M., Satoh, A., Hino, A., Furuki, K., & Imaizumi, T. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1588 · Cited by 70
Mechanisms of insulin resistance in the amygdala: Influences on food intake
Areias, M. F. C., & Prada, P. O. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.01.003 · Cited by 68
Insulin and cognitive function in humans: experimental data and therapeutic considerations
Strachan, M. W. J. (2005) · Biochemical Society Transactions · doi:10.1042/bst0331037 · Cited by 68
Deng, H., Lin, Y., Badin, M., Vasilcanu, D., Strömberg, T., Jernberg‐Wiklund, H., Sehat, B., & Larsson, O. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.12.038 · Cited by 68
Hunter, R. W., & Hers, I. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03637.x · Cited by 68
Gallagher, E. J., Alikhani, N., Tobin‐Hess, A., Blank, J., Buffin, N. J., Zelenko, Z., Tennagels, N., Ulrich, W., & LeRoith, D. (2013) · Diabetes · doi:10.2337/db13-0249 · Cited by 68
Role of Insulin Receptor in the Regulation of Glucose Uptake in Neonatal Hepatocytes
Nevado, C., Valverde, Á. M., & Benito, M. (2006) · Endocrinology · doi:10.1210/en.2005-1663 · Cited by 67
IRS‐2 branch of IGF‐1 receptor signaling is essential for appropriate timing of myelination
Freude, S., Leeser, U., Müller, M., Hettich, M. M., Udelhoven, M., Schilbach, K., Tobe, K., Kadowaki, T., Köhler, C. N., Schröder, H., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05631.x · Cited by 66
Federici, M., Porzio, O., Lauro, D., Borboni, P., Giovannone, B., Zucaro, L., Hribal, M. L., & Sesti, G. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.4935 · Cited by 66
Malaguarnera, R., Nicolosi, M. L., Sacco, A., Morcavallo, A., Vella, V., Voci, C., Spatuzza, M., Xu, S., Iozzo, R. V., Vigneri, R., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3177 · Cited by 66
Self-citationPisano, A., Santolla, M. F., Francesco, E. M. D., Marco, P. D., Rigiracciolo, D. C., Perri, M. G., Vivacqua, A., Abonante, S., Cappello, A. R., Dolce, V., et al. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22518 · Cited by 66
Self-citationBrugts, M. P., Ranke, M. B., Hofland, L. J., van der Wansem, K., Weber, K., Frystyk, J., Lamberts, S. W. J., & Janssen, J. A. M. J. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2454 · Cited by 65
Mimeault, M., & Batra, S. K. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.08.001 · Cited by 65
The B Isoform of the Insulin Receptor Signals More Efficiently Than the A Isoform in HepG2 Cells
Kosaki, A., Pillay, T. S., Xu, L., & Webster, N. J. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.35.20816 · Cited by 64
Aleem, E. A., Nehrbass, D., Klimek, F., Mayer, D., & Bannasch, P. (2011) · Toxicologic Pathology · doi:10.1177/0192623310396905 · Cited by 64
Haluska, P., Menefee, M. E., Plimack, E. R., Rosenberg, J. E., Northfelt, D., LaVallee, T. M., Shi, L., Yu, X., Burke, P., Huang, J., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0114 · Cited by 64
Serrano, R., Villar, M., Martínez, C., Carrascosa, J. M., Gallardo, N., & Andrés, A. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01635 · Cited by 64
Cui, H., Wu, F., Sun, Y., Fan, G., & Wang, Q. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-356 · Cited by 64
Insulin binding sites on rat liver nuclear membranes: Biochemical and immunofluorescent studies
Horvat, A. (1978) · Journal of Cellular Physiology · doi:10.1002/jcp.1040970106 · Cited by 63
Slaaby, R. (2015) · Scientific Reports · doi:10.1038/srep07911 · Cited by 63
Insulin and Hybrid Insulin/IGF Receptors Are Major Regulators of Breast Cancer Cells
Frasca, F., Pandini, G., Vigneri, R., & Goldfine, I. D. (2003) · Breast Disease · doi:10.3233/bd-2003-17108 · Cited by 62
Self-citationHMGA1 is a novel downstream nuclear target of the insulin receptor signaling pathway
CHIEFARI, E. D., Nevolo, M. T., Arcidiacono, B., Maurizio, E., Nocera, A., Iiritano, S., Sgarra, R., Possidente, K., Palmieri, C., Paonessa, F., et al. (2012) · Scientific Reports · doi:10.1038/srep00251 · Cited by 62
Zhao, H., Desai, V., Wang, J., Epstein, D. M., Miglarese, M. R., & Buck, E. A. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0327 · Cited by 62
Andres, S. F., Simmons, J. G., Mah, A. T., Santoro, M. A., Landeghem, L. V., & Lund, P. K. (2013) · Journal of Cell Science · doi:10.1242/jcs.132985 · Cited by 62
Ganglioside GM3 as a gatekeeper of obesity‐associated insulin resistance: Evidence and mechanisms
Lipina, C., & Hundal, H. S. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.09.018 · Cited by 61
Dombrowski, F., Mathieu, C., & Evert, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2787 · Cited by 61
Heni, M., Hennenlotter, J., Scharpf, M. O., Lutz, S. Z., Schwentner, C., Todenhöfer, T., Schilling, D., Kühs, U., Gerber, V., Machicao, F. E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050953 · Cited by 60
Dichotomy of decorin activity on the insulin‐like growth factor‐I system
Morrione, A., Neill, T., & Iozzo, R. V. (2013) · FEBS Journal · doi:10.1111/febs.12149 · Cited by 60
Self-citationMarco, P. D., Cirillo, F., Vivacqua, A., Malaguarnera, R., Belfiore, A., & Maggiolini, M. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00030 · Cited by 60
Self-citationRamos, F. J., Langlais, P. R., Hu, D., Dong, L., & Liu, F. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00609.2005 · Cited by 60
Chapter 2 The Structure and Function of Insulin
Weiss, M. A. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00602-x · Cited by 59
Proinsulin Concentration Is an Independent Predictor of All-Cause and Cardiovascular Mortality
Alssema, M., Dekker, J. M., Nijpels, G., Stehouwer, C. D. A., Bouter, L. M., & Heine, R. J. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.860 · Cited by 59
Huang, Z., Bodkin, N. L., Ortmeyer, H. K., Hansen, B. C., & Shuldiner, A. R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117447 · Cited by 59
Wang, X.-Q., Sheu, S. L., Wilson, H., Seeger, M., Iordanov, H., Gatla, N., Whittington, A., Bach, D. Q., Lu, J.-Y., & Paller, A. S. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.532 · Cited by 58
Eckardt, K., May, C., Koenen, M., & Eckel, J. (2007) · Diabetologia · doi:10.1007/s00125-007-0815-9 · Cited by 57
Altered Expression of Insulin Receptor Isoforms in Breast Cancer
Huang, J., Morehouse, C., Streicher, K. L., Higgs, B. W., Gao, J., Czapiga, M., Boutrin, A., Zhu, W., Brohawn, P. Z., Chang, Y. S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026177 · Cited by 56
Daughaday, W. H., & Trivedi, B. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.1.1618998 · Cited by 56
Morcavallo, A., Gaspari, M., Pandini, G., Palummo, A., Cuda, G., Larsen, M. R., Vigneri, R., & Belfiore, A. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0484 · Cited by 54
Self-citationThe human insulin receptor mRNA contains a functional internal ribosome entry segment
Spriggs, K. A., Cobbold, L. C., Ridley, S. H., Coldwell, M. J., Bottley, A., Bushell, M., Willis, A. E., & Siddle, K. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp623 · Cited by 54
Ziegler, A. N., Chidambaram, S., Forbes, B. E., Wood, T. L., & Levison, S. W. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.537597 · Cited by 53
Decorin differentially modulates the activity of insulin receptor isoform A ligands
Morcavallo, A., Buraschi, S., Xu, S., Belfiore, A., Schaefer, L., Iozzo, R. V., & Morrione, A. (2014) · Matrix Biology · doi:10.1016/j.matbio.2013.12.010 · Cited by 53
Self-citationInsulin mediated DNA damage in mammalian colon cells and human lymphocytes in vitro
Othman, E. M., Leyh, A., & Stopper, H. (2013) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2013.03.006 · Cited by 53
Menting, J. G. T., Lawrence, C., Kong, G. K.-W., Margetts, M. B., Ward, C. W., & Lawrence, M. C. (2015) · Structure · doi:10.1016/j.str.2015.04.016 · Cited by 53
Self-citationStaiger, K., Hennige, A. M., Staiger, H., et al. (2007) · Hormone and Metabolic Research · doi:10.1055/s-2007-957352 · Cited by 52
Westermeier, F., Salomón, C., Farías, M., Arroyo, P., Fuenzalida, B., Sáez, T., Salsoso, R., Sanhueza, C., Guzmán‐Gutiérrez, E., Pardo, F., et al. (2014) · The FASEB Journal · doi:10.1096/fj.14-254219 · Cited by 52
RBM4 Promotes Pancreas Cell Differentiation and Insulin Expression
Lin, J.-C., Yan, Y., Hsieh, W.-K., Peng, P.-J., Su, C.-H., & Tarn, W. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.01266-12 · Cited by 51
Kamińska, D., Hämäläinen, M., Cederberg, H., Käkelä, P., Venesmaa, S., Miettinen, P. S., Ilves, I., Herzig, K., Kolehmainen, M., Karhunen, L. J., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-3097-4 · Cited by 50
Heidegger, I. M., Ofer, P., Doppler, W., Rotter, V., Klocker, H., & Massoner, P. (2012) · Endocrinology · doi:10.1210/en.2012-1348 · Cited by 50
Echeverria, G. V., & Cooper, T. A. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1020 · Cited by 50
Quantifying insulin receptor isoform expression in FFPE breast tumors
Harrington, S. C., Weroha, S. J., Reynolds, C. A., Suman, V. J., Lingle, W. L., & Haluska, P. (2012) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2012.04.001 · Cited by 49
Inokuchi, J. (2014) · Glycoconjugate Journal · doi:10.1007/s10719-013-9516-4 · Cited by 49
Avino, S., Marco, P. D., Cirillo, F., Santolla, M. F., Francesco, E. M. D., Perri, M. G., Rigiracciolo, D. C., Dolce, V., Belfiore, A., Maggiolini, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10348 · Cited by 49
Self-citationVersteyhe, S., Klaproth, B., Borup, R., Palsgaard, J., Jensen, M., Gray, S. G., & MEYTS, P. D. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00098 · Cited by 48
Engberding, N., Martín, A. S., Martín-Garrido, A., Koga, M., Pounkova, L., Lyons, E., Lassegue, B. P., & Griendling, K. K. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.181727 · Cited by 48
Bryhni, B., Arnesen, E., & Jenssen, T. G. (2010) · BMC Endocrine Disorders · doi:10.1186/1472-6823-10-21 · Cited by 48
Rowzee, A. M., Ludwig, D. L., & Wood, T. L. (2009) · Endocrinology · doi:10.1210/en.2008-1473 · Cited by 47
Berlato, C., & Doppler, W. (2009) · Endocrinology · doi:10.1210/en.2008-0668 · Cited by 47
Liu, B. A., Engelmann, B. W., Jablonowski, K. D., Higginbotham, K., Stergachis, A. B., & Nash, P. (2012) · Cell Communication and Signaling · doi:10.1186/1478-811x-10-27 · Cited by 47
Rojas, J. X. S., Frutos, M. G.-S., Horrillo, D., Lauzurica, N., Oliveros, E., Carrascosa, J. M., Fernández‐Agulló, T., & Ros, M. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glv117 · Cited by 47
Kasprzak, A., & Adamek, A. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1666 · Cited by 46
The IGF-Trap: Novel Inhibitor of Carcinoma Growth and Metastasis
Wang, N., Rayes, R. F., Elahi, S. M., Lu, Y., Hancock, M. A., Massie, B., Rowe, G. E., Aomari, H., Hossain, S. M., Durocher, Y., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0751 · Cited by 46
Lee, J. S., Kang, J.-H., Boo, H., Hwang, S.-J., Hong, S., Lee, S.-C., Park, Y.-J., Chung, T.-M., Youn, H., Lee, S. M., et al. (2015) · Nature Communications · doi:10.1038/ncomms9499 · Cited by 46
Wu, Y.-C., Zhu, M., & Robertson, D. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042483 · Cited by 45
Receptor-isoform-selective insulin analogues give tissue-preferential effects
Vienberg, S. G., Bouman, S. D., Sørensen, H., Stidsen, C. E., Kjeldsen, T., Glendorf, T., Sørensen, A. R., Olsen, G. S., Andersen, B., & Nishimura, E. (2011) · Biochemical Journal · doi:10.1042/bj20110880 · Cited by 45
Oh, Y. S., Khil, L., Cho, K., Ryu, S. J., Ha, M. K. A., Cheon, G. J., Lee, T. S., Yoon, J. W., Jun, H., & Park, S. C. (2008) · Diabetologia · doi:10.1007/s00125-008-0993-0 · Cited by 45
Iovino, S., Burkart, A., Kriauciunas, K. M., Warren, L., Hughes, K. J., Molla, M. N., Lee, Y.-K., Patti, M., & Kahn, C. R. (2014) · Diabetes · doi:10.2337/db14-0109 · Cited by 45
Morcavallo, A., Stefanello, M., Iozzo, R. V., Belfiore, A., & Morrione, A. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00220 · Cited by 44
Self-citationDirect Recruitment of Insulin Receptor and ERK Signaling Cascade to Insulin-Inducible Gene Loci
Nelson, J. D., LeBoeuf, R. C., & Bomsztyk, K. (2010) · Diabetes · doi:10.2337/db09-1806 · Cited by 44
Saeki, K., Yasugi, E., Okuma, E., Breit, S. N., Nakamura, M., Toda, T., Kaburagi, Y., & Yuo, A. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00512.2004 · Cited by 44
Hansen, B. F., Glendorf, T., Hegelund, A. C., Lundby, A., Lützen, A., Slaaby, R., & Stidsen, C. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034274 · Cited by 43
Intrinsic expression of host genes and intronic miRNAs in prostate carcinoma cells
Sikand, K., Slane, S. D., & Shukla, G. C. (2009) · Cancer Cell International · doi:10.1186/1475-2867-9-21 · Cited by 43
Loss of imprinting of IGF2 and the epigenetic progenitor model of cancer.
Leick, M. B., Shoff, C. J., Wang, E., Congress, J. L., & Gallicano, G. I. (2012) · Europe PMC (PubMed Central) · Cited by 42
Dinchuk, J. E., Cao, C., Huang, F., Reeves, K. A., Wang, J., Myers, F., Cantor, G. H., Zhou, X., Attar, R. M., Gottardis, M. M., et al. (2010) · Endocrinology · doi:10.1210/en.2010-0032 · Cited by 42
Caveolins and membrane cholesterol
Ikonen, E., Heino, S., & Lusa, S. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320121 · Cited by 42
Yakar, S., Kim, H., Zhao, H., Toyoshima, Y., Pennisi, P. A., Gavrilova, O., & LeRoith, D. (2005) · Pediatric Nephrology · doi:10.1007/s00467-004-1613-y · Cited by 42
Marchand, A., Atassi, F., Mougenot, N., Clergue, M., Codoni, V., Berthuin, J., Proust, C., Trégouët, D., Hulot, J., & Lompré, A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.01.010 · Cited by 42
Vella, V., Malaguarnera, R., Nicolosi, M. L., Palladino, C., Spoleti, C. B., Massimino, M., Vigneri, P. G., Purrello, M., Ragusa, M., Morrione, A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18020 · Cited by 42
Self-citationTada, Y., Yamaguchi, Y., Kinjo, T., Song, X., Akagi, T., Takamura, H., Ohta, T., Yokota, T., & Koide, H. (2014) · Oncogene · doi:10.1038/onc.2013.599 · Cited by 41
The location and characterisation of the O‐linked glycans of the human insulin receptor
Sparrow, L. G., Gorman, J. J., Strike, P. M., Robinson, C. P., McKern, N. M., Epa, V. C., & Ward, C. W. (2006) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21261 · Cited by 41
Hossain, M. U., Khan, M. A., Rakib-Uz-Zaman, S. M., Ali, M. T., Islam, M. S., Keya, C. A., & Salimullah, M. (2016) · BioMed Research International · doi:10.1155/2016/3187647 · Cited by 41
Changes in insulin and IGF-I receptor expression during differentiation of human preadipocytes
Bäck, K., & Arnqvist, H. J. (2009) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2008.06.004 · Cited by 40
Santoro, M., Masciullo, M., Bonvissuto, D., Bianchi, M. L. E., Michetti, F., & Silvestri, G. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1681-z · Cited by 40
Perseghin, G., Caumo, A., Arcelloni, C., Benedini, S., Lanzi, R., Pagliato, E., Sereni, L. P., Testolin, G., Battezzati, A., Comı, G., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.7.2112 · Cited by 40
Physiopathological function of hematoside (GM3 ganglioside)
Inokuchi, J. (2011) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.87.179 · Cited by 40
Autocrine loop for IGF-I receptor signaling in SLUG-mediated epithelial-mesenchymal transition
Koga (1992) · International Journal of Oncology · doi:10.3892/ijo_00000155 · Cited by 40
Federici, M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2911 · Cited by 40
GPER1 is regulated by insulin in cancer cells and cancer-associated fibroblasts
Marco, P. D., Romeo, E., Vivacqua, A., Malaguarnera, R., Abonante, S., Romeo, F., Pezzi, V., Belfiore, A., & Maggiolini, M. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0245 · Cited by 39
Self-citationGreenall, S. A., Bentley, J. D., Pearce, L. A., Scoble, J. A., Sparrow, L. G., Bartone, N. A., Xiao, X., Baxter, R. C., Cosgrove, L. J., & Adams, T. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.432013 · Cited by 39
The metabolic and mitogenic properties of basal insulin analogues
Tennagels, N., & Ulrich, W. (2013) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2012.754474 · Cited by 39
Targeting Insulin Receptor with a Novel Internalizing Aptamer
Iaboni, M., Fontanella, R., Rienzo, A., Capuozzo, M., Nuzzo, S., Santamaria, G., Catuogno, S., Condorelli, G., de Franciscis, V., & Esposito, C. L. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2016.73 · Cited by 39
GH/IGF-I/insulin system in centenarians
Vitale, G., Barbieri, M., Kamenetskaya, M., & Paolisso, G. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.12.001 · Cited by 39
Sciacca, L., Cassarino, M. F., Genua, M., Vigneri, P. G., Pennisi, M. G., Malandrino, P., Squatrito, S., PEZZINO, V., & Vigneri, R. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24635 · Cited by 38
Self-citationMagee, B. A., Shooter, G. K., Wallace, J. C., & Francis, G. L. (1999) · Biochemistry · doi:10.1021/bi9910070 · Cited by 38
Chisalita, S. I., Johansson, G. S., Liefvendahl, E., Bäck, K., & Arnqvist, H. J. (2009) · Journal of Molecular Endocrinology · doi:10.1677/jme-09-0021 · Cited by 38
Jensen, M., Palsgaard, J., Borup, R., MEYTS, P. D., & Schäffer, L. (2008) · Biochemical Journal · doi:10.1042/bj20080279 · Cited by 37
Jiang, L., Zhu, W., Streicher, K. L., Morehouse, C., Brohawn, P. Z., Ge, X., Dong, Z., Yin, X., Zhu, G., Gu, Y., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-131 · Cited by 37
Vincent, E. E., Elder, D. J. E., Curwen, J., Kilgour, E., Hers, I., & Tavaré, J. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066963 · Cited by 37
Insulin activates the insulin receptor to downregulate the PTEN tumour suppressor
Liu, J., Grieve, S., Boudreau, J. R., Yeung, B., Lo, S., Chamberlain, G., Yu, F. P. S., Sun, T., Papanicolaou, T., Lam, A., et al. (2013) · Oncogene · doi:10.1038/onc.2013.347 · Cited by 37
Insulin Mimetic Peptide Disrupts the Primary Binding Site of the Insulin Receptor
Lawrence, C., Margetts, M. B., Menting, J. G. T., Smith, N. A., Smith, B. J., Ward, C. W., & Lawrence, M. C. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.732180 · Cited by 37
Self-citationZhong, H., Fazenbaker, C. A., Chen, C., Breen, S., Huang, J., Yao, X., Ren, P., Yao, Y., Herbst, R., & Hollingsworth, R. E. (2016) · Oncogene · doi:10.1038/onc.2016.248 · Cited by 37
Wiberg, B., Sundström, J., Zethelius, B., & Lind, L. (2008) · Diabetologia · doi:10.1007/s00125-008-1171-0 · Cited by 36
Flannery, C. A., Saleh, F., Choe, G. H., Selen, D. J., Kodaman, P. H., Kliman, H. J., Wood, T. L., & Taylor, H. S. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1795 · Cited by 36
Kwon, H., Lee, J. W., Jeong, K., Jang, D., & Pak, Y. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.02.002 · Cited by 35
Insulin receptor isoforms are differently expressed during human osteoblastogenesis
Avnet, S., Perut, F., Salerno, M., Sciacca, L., & Baldini, N. (2012) · Differentiation · doi:10.1016/j.diff.2012.02.002 · Cited by 35
Self-citationBesic, V., Shi, H., Stubbs, R. S., & Hayes, M. T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119270 · Cited by 35
Grb10 adapter protein as regulator of insulin‐like growth factor receptor signaling
Morrione, A. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10363 · Cited by 35
Self-citationBaudry, A., Lamothe, B., Bucchini, D., Jami, J., Montarras, D., Pinset, C., & Joshi, R. L. (2001) · FEBS Letters · doi:10.1016/s0014-5793(00)02435-2 · Cited by 35
Chan, J. Y., LaPara, K. S., & Yee, D. (2016) · Oncogene · doi:10.1038/onc.2015.488 · Cited by 35
Myotubularin-related protein 7 inhibits insulin signaling in colorectal cancer
Weidner, P., Söhn, M., Gutting, T., Friedrich, T., Gaiser, T., Magdeburg, J., Kienle, P., Ruh, H., Hopf, C., Behrens, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10466 · Cited by 35
The Insulin and IGF-I Pathway in Endocrine Glands Carcinogenesis
Malaguarnera, R., Morcavallo, A., & Belfiore, A. (2012) · Journal of Oncology · doi:10.1155/2012/635614 · Cited by 34
Self-citationYe, X., Kohtz, A. S., Pollonini, G., Riccio, A., & Alberini, C. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141078 · Cited by 34
Association Between Insulin Resistance and Luminal B Subtype Breast Cancer in Postmenopausal Women
Nam, S., Park, S., Park, H. S., Kim, S., Kim, J. Y., & Kim, S. I. (2016) · Medicine · doi:10.1097/md.0000000000002825 · Cited by 34
Rajapaksha, H., & Forbes, B. E. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00107 · Cited by 33
Mechanism and Role of Insulin Receptor Endocytosis
McClain, D. A. (1992) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199209000-00009 · Cited by 33
Structural and functional heterogeneity of insulin receptors
Joost, H. (1995) · Cellular Signalling · doi:10.1016/0898-6568(94)00071-i · Cited by 32
Intrinsic Resistance to Cixutumumab Is Conferred by Distinct Isoforms of the Insulin Receptor
Forest, A., Amatulli, M., Ludwig, D. L., Damoci, C. B., Wang, Y., Burns, C. A., Donoho, G. P., Zanella, N., Fiebig, H., Prewett, M. C., et al. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0279 · Cited by 32
Yao, H., Liu, X., Chen, S., Xia, W., & Chen, X. (2015) · PubMed Central · Cited by 32
Frago, S., Nicholls, R. D., Strickland, M., Hughes, J., Williams, C., Garner, L. I., Surakhy, M., Maclean, R., Rezgui, D., Prince, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513023113 · Cited by 32
Signaling steps in the induction of genomic damage by insulin in colon and kidney cells
Othman, E. M., Hintzsche, H., & Stopper, H. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.12.010 · Cited by 31
FAK and Nanog Cross Talk with p53 in Cancer Stem Cells
Golubovskaya, V. (2013) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520611313040006 · Cited by 31
Žáková, L., Kletvíková, E., Lepšı́k, M., Collinsová, M., Watson, C. J., Turkenburg, J. P., Jiráček, J., & Brzozowski, A. M. (2014) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s1399004714017775 · Cited by 31
Essential role of insulin-like growth factor 2 in resistance to histone deacetylase inhibitors
Lee, S.-C., Min, H.-Y., Jung, H. J., Park, K. H., Hyun, S., Cho, J., Woo, J. K., Kwon, S., Lee, H., Johnson, F. M., et al. (2016) · Oncogene · doi:10.1038/onc.2016.92 · Cited by 31
Křížková, K., Chrudinová, M., Povalová, A., Selicharová, I., Collinsová, M., Vaněk, V., Brzozowski, A. M., Jiráček, J., & Žáková, L. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00140 · Cited by 31
IGF-1R inhibition sensitizes breast cancer cells to ATM-related kinase (ATR) inhibitor and cisplatin
O’Flanagan, C. H., O’Shea, S., Lyons, A., Fogarty, F., McCabe, N., Kennedy, R. D., & O’Connor, R. (2016) · Oncotarget · doi:10.18632/oncotarget.10862 · Cited by 31
Corbin, J., Bhaskar, V., Goldfine, I. D., Issafras, H., Bedinger, D., Lau, A., Michelson, K. S., Gross, L. M., Maddux, B. A., Kuan, H. F., et al. (2013) · mAbs · doi:10.4161/mabs.26871 · Cited by 30
Sekimoto, J., Kabayama, K., Gohara, K., & Inokuchi, J. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.12.019 · Cited by 30
Bäck, K., Brännmark, C., Strålfors, P., & Arnqvist, H. J. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.04.005 · Cited by 30
Prince, S., Foulstone, E. J., Zaccheo, O., Williams, C., & Hassan, A. B. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0509 · Cited by 30
Regulation of cancer cell proliferation by caveolin-2 down-regulation and re-expression
Pak, Y. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.958 · Cited by 30
EMT reversal in human cancer cells after IR knockdown in hyperinsulinemic mice
Zelenko, Z., Gallagher, E. J., Antoniou, I. M., Sachdev, D., Nayak, A., Yee, D., & LeRoith, D. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0142 · Cited by 30
Wu, A., Sciacca, L., & Baserga, R. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10261 · Cited by 29
Self-citationRostoker, R., Bitton-Worms, K., Caspi, A., Shen‐Orr, Z., & LeRoith, D. (2013) · Endocrinology · doi:10.1210/en.2012-2263 · Cited by 29
Kara, I., Poggi, M., Bonardo, B., Govers, R., Landrier, J., Tian, S., Leibiger, I. B., Day, R. W., Creemers, J. W. M., & Peiretti, F. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.592543 · Cited by 29
Bäck, K., Islam, R., Johansson, G., Chisalita, S. I., & Arnqvist, H. J. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0261 · Cited by 29
Lin28: an emerging important oncogene connecting several aspects of cancer
Wang, H., Zhao, Q., Deng, K., Guo, X., & Xia, J. (2016) · Tumor Biology · doi:10.1007/s13277-015-4759-2 · Cited by 29
Wang, X., Wang, M., Li, H., Lan, X., Liu, L., Li, J., Li, Y., Li, J., Yi, J., Du, X., et al. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.08.021 · Cited by 28
Othman, E. M., Kreissl, M. C., Kaiser, F. R., Arias-Loza, P.-A., & Stopper, H. (2013) · Endocrinology · doi:10.1210/en.2012-1768 · Cited by 28
Wang, J., Kang, M., Qin, Y., Wei, Z., Xiao, J.-J., & Wang, R. (2015) · Europe PMC (PubMed Central) · Cited by 28
Brierley, G. V., Macaulay, S. L., Forbes, B. E., Wallace, J. C., Cosgrove, L. J., & Macaulay, V. M. (2010) · Endocrinology · doi:10.1210/en.2009-1006 · Cited by 27
Kwon, H., Jeong, K., Hwang, E. M., Park, J., & Pak, Y. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01079.x · Cited by 27
Bedinger, D., Goldfine, I. D., Corbin, J., Roell, M. K., & Adams, S. H. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.221309 · Cited by 27
Escribano, Ó., Gómez‐Hernández, A., Díaz-Castroverde, S., Nevado, C., García, G., Otero, Y. F., Perdomo, L., Beneit, N., & Benito, M. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.03.008 · Cited by 27
Tsukagawa, E., Adachi, H., Hirai, Y., et al. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04496.x · Cited by 27
Cited by
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
ImmunoPET: Concept, Design, and Applications
Wei, W., Rosenkrans, Z. T., Liu, J., Huang, G., Luo, Q.-Y., & Cai, W. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00738 · Cited by 484
Hyperinsulinemia in Obesity, Inflammation, and Cancer
Zhang, A. M. Y., Wellberg, E. A., Kopp, J. L., & Johnson, J. D. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0250 · Cited by 305
Insulin-like growth factors: Ligands, binding proteins, and receptors
LeRoith, D., Holly, J. M. P., & Forbes, B. E. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101245 · Cited by 303
Role of the Blood-Brain Barrier in Central Nervous System Insulin Resistance
Rhea, E. M., & Banks, W. A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00521 · Cited by 263
Metadata
- Authors
- Belfiore, A., Malaguarnera, R., Vella, V., Lawrence, M. C., Sciacca, L., Frasca, F., Morrione, A., & Vigneri, R.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2017-06-19
- Volume
- 38
- Issue
- 5
- Pages
- 379-431
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2715761994
- Cited by
- 375
- References
- 444
- FWCI
- 20.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.